NCT06163157

Brief Summary

In this study, it is planned to investigate the effect of connective tissue massage on symptom severity, autonomic functions, psychological state and quality of life in individuals with erectile dysfunction symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 8, 2023

Completed
13 days until next milestone

Study Start

First participant enrolled

December 21, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2024

Completed
Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

1 year

First QC Date

November 20, 2023

Last Update Submit

December 22, 2024

Conditions

Keywords

Erectile dysfunctionConnective tissue massage

Outcome Measures

Primary Outcomes (2)

  • The International Index of Erectile Function (IIEF-5)

    İt is a 5-question questionnaire used to assess erectile dysfunction. Patients' answers to each question are scored between 1 and 5. A total score above 21 indicates normal erectile function, while a score of 21 and below indicates ED. According to the total score obtained from the scale, ED is divided into 4 categories. Severe (1-7), moderate (8-11), moderate to mild (12-16), mild (17-21) and no ED (22-25).

    Change from baseline at 4 weeks

  • Composite Autonomic Symptom Score (COMPASS 31)

    İt is a 31-question questionnaire that assesses autonomic symptoms in 6 different areas: orthostatic intolerance, vasomotor, secretomotor, gastrointestinal, bladder function and pupillomotor. Survey score varies between 0-100 points. A high score on the questionnaire indicates the presence and severity of autonomic dysfunction.

    Change from baseline at 4 weeks

Secondary Outcomes (2)

  • Depression Anxiety Stress Scale (DASS-21)

    Change from baseline at 4 weeks

  • Quality of Life Questionnaire (SF-36)

    Change from baseline at 4 weeks

Study Arms (2)

Control roup

NO INTERVENTION

The control group will receive standard treatment (lifestyle recommendations).

CTM group

EXPERIMENTAL

In addition to the standard treatment, connective tissue massage will be applied to the CTM group.

Other: Connective tissue massage(CTM)

Interventions

CTM will be applied by a trained physiotherapist for 3 days/week for 4 weeks. Application time will be approximately 15-20 minutes.

CTM group

Eligibility Criteria

Age20 Years - 65 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male subjects aged 20-65 years with ED complaints for at least 6 months will be included in the study. In addition, sexually active individuals will be included in the study

You may not qualify if:

  • Patients with diabetes and renal diseases, uncontrolled hypertension, priapism, pacemaker users, history of psychiatric or psychological illness, skin lesions/ulcer in the penis or lumbosacral region, and patients who are unable to cooperate will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bitlis Eren University

Bitlis, 13000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Erectile Dysfunction

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 20, 2023

First Posted

December 8, 2023

Study Start

December 21, 2023

Primary Completion

December 21, 2024

Study Completion

December 21, 2024

Last Updated

December 27, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations